Ondansetron
9
3
4
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
33%
3 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section
Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Tonsillectomy
Intravenous Versus Perineural Ondansetron for Laparoscopic Sleeve Gastrectomy
Peritoneal Lavage Using Saline or Saline With Ondansetron for Pain Control After Laparoscopic Cholecystectomy
The Effect of Intravenous Infusion of Tramadol-ondansetron on Recovery After Caesarean Section.
Mode of Action of Ondansetron, a 5-HT Receptor 3 Antagonist, in Lactulose Induced Diarrhoea
Effects of Ondansetron on Hemodynamics in Cesarean Section Under Spinal Anesthesia
Anti-shivering Effect of Ondansetron
Ondansetron and the QT Interval In Adult Emergency Department Patients